
A recent medical examination found a small growth on Pope Leo XIV's lung. He said doctors would remove it during surgery this week.
4:15 PMThe New York Times9 stories from 6 sources
Supporting Articles

A recent medical examination found a small growth on Pope Leo XIV's lung. He said doctors would remove it during surgery this week.
4:15 PMThe New York Times
Millions of people are using chatbots for mental health support. But systems limited to conversation cannot provide the human presence, clinical judgment, or broader care that recovery may require.
12:00 AMFinancial Times
Scientists identified a previously unknown pathway at the back of the eye that drains fluid and waste in mice. The discovery could point to new treatments for glaucoma, macular degeneration, and other conditions that cause blindness.
2:01 AMScienceDaily
Summary
A recent medical examination found a small growth on Pope Leo XIV's lung. He said doctors would remove it during surgery this week.
The immediate change is that the pope now faces a surgical procedure tied to an
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The growth's pathology and the pope's recovery will determine both the medical risk and any near-term impact on the papacy.
5 stories · 4 sources

Summary
Millions of people are using chatbots for mental health support. But systems limited to conversation cannot provide the human presence, clinical judgment, or broader care that recovery may require.
The shift is from occasional digital support to AI becoming a first-line mental health service.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
AI may widen access to mental health help while making inadequate care easier to scale.

Summary
Scientists identified a previously unknown pathway at the back of the eye that drains fluid and waste in mice. The discovery could point to new treatments for glaucoma, macular degeneration, and other conditions that cause blindness.
The finding adds a previously unrecognized waste-clearance route to the biology of the eye, potentially
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A new route for clearing fluid and waste could provide drug developers with an entirely new target for major blinding diseases.
A curated list of other prominent stories from this day.

Russian researchers found that brazzein, a sweet-tasting protein, may help reduce spikes in blood sugar. The finding points to a possible role for the protein in developing lower-impact sweeteners or diabetes-related products.
8:23 AMAl Jazeera
In mice, consuming olive oil before carbohydrates slowed digestion and triggered hormone and nerve signals that improved blood-sugar regulation. The effect also appeared in mice with type 2 diabetes.
12:32 AMScienceDaily
Summary
Russian researchers found that brazzein, a sweet-tasting protein, may help reduce spikes in blood sugar. The finding points to a possible role for the protein in developing lower-impact sweeteners or diabetes-related products.
The evidence is still at the research stage, so brazzein is not yet an established
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A sweetener that limits blood sugar spikes could matter for diabetes management and food formulation if human trials validate the result.

Summary
In mice, consuming olive oil before carbohydrates slowed digestion and triggered hormone and nerve signals that improved blood-sugar regulation. The effect also appeared in mice with type 2 diabetes.
The important shift is a meal-timing mechanism that changed glucose handling before the carbohydrates arrived,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
If human studies replicate the effect, meal sequence could offer a simple supplement to dietary and diabetes-management strategies.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!